Stay updated on OBE2109 Efficacy in Heavy Menstrual Bleeding Clinical Trial
Sign up to get notified when there's something new on the OBE2109 Efficacy in Heavy Menstrual Bleeding Clinical Trial page.
Latest updates to the OBE2109 Efficacy in Heavy Menstrual Bleeding Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedPublication note stating automatic fill from PubMed was added and the page revision updated to v3.3.2 (replacing the previous v3.2.0). These are minor metadata updates that do not affect study content.SummaryDifference0.1%
- Check28 days agoChange DetectedRemoved the government funding status notice as an operational update; it does not affect trial details, eligibility criteria, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check42 days agoChange DetectedNo additions or deletions affecting the core content of the study record were detected for NCT03070951, including title, conditions, interventions, locations, and eligibility criteria.SummaryDifference0.2%
- Check64 days agoChange DetectedAdded a new medical research citation (PRIMROSE 1 & 2 study) related to linzagolix for uterine fibroids; no deletions were observed.SummaryDifference2%
- Check71 days agoChange Detected- Added a government funding lapse notice with operating status guidance and a link to cc.nih.gov and opm.gov. - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%
- Check78 days agoChange DetectedUpdate page revision from v3.0.2 to v3.1.0 to reflect a new release.SummaryDifference0.1%
Stay in the know with updates to OBE2109 Efficacy in Heavy Menstrual Bleeding Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OBE2109 Efficacy in Heavy Menstrual Bleeding Clinical Trial page.